XML 65 R45.htm IDEA: XBRL DOCUMENT v3.23.3
Condensed Consolidated Statements of Operations - USD ($)
$ in Thousands
 3 Months Ended 9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
Revenue $ 5,193 $ 3,923 $ 12,790 $ 9,172
Cost of goods sold 589 701 2,023 1,442
Gross profit 4,604 3,222 10,767 7,730
Operating expenses:        
Research and development 9,367 4,808 21,871 15,091
Sales and marketing 4,689 3,030 11,430 8,881
General and administrative 9,025 3,495 17,498 8,425
Loss from operations (18,477) (8,111) (40,032) (24,667)
Interest income 116 49 187 75
Interest expense (4) 0 (13) 0
Loss on equity issuance 0 0 (4,171) 0
Other expense, net (13) (31) (56) (71)
Loss before income taxes (1,286) (8,093) (23,521) (24,642)
Income tax expense 0 0 8 3
Net loss available to common stockholders (1,286) (8,093) (23,529) (24,645)
Deemed dividend related to Series B-2 preferred stock down round provision 0 0 (2,981) 0
Undeclared dividends on Series A preferred stock (458) 0 (458) 0
Net loss attributable to common stockholders $ (1,744) $ (8,093) $ (26,968) $ (24,645)
Net loss per share, basic (in dollars per share) $ (0.13) $ (25.95) $ (5.68) $ (82.17)
Net loss per share, diluted (in dollars per share) $ (0.13) $ (25.95) $ (5.68) $ (82.17)
Weighted average common shares outstanding, basic (in shares) 13,173,422 311,823 4,749,849 299,936
Weighted average common shares outstanding, diluted (in shares) 13,173,422 311,823 4,749,849 299,936
Tranche and warrant liability        
Operating expenses:        
Gain (loss) on derivatives $ (2,812) $ 0 $ 660 $ 21
Contingent earnout liability        
Operating expenses:        
Gain (loss) on derivatives $ 19,904 $ 0 $ 19,904 $ 0